|
|
Other links at Articles > Gastroenterology |
| 3. |
Pegylated Interferon Alpha-2a Advantageous in Dialysis Patients With Hepatitis C
|
|
|
Once-weekly treatment with pegylated interferon alpha-2a is both more effective and safer than standard interferon alpha-2a three times a week for interferon-naive dialysis patients with chronic hepatitis C virus (HCV) infection, according to a report by Taiwanese researchers published in the April issue of Gut. Reuters Health Information
|
|
|